Metraipolis › archive › dc_f3cc69218f55

PD-L1-armored CD19/CD22 dual-targeted CAR-T cell co-infusion bridging to allogeneic hematopoietic stem cell transplantation achieves 7-year sustained… — Europe PMC PMID:42125659

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42125659
DOI
10.3389/fimmu.2026.1797562
License (as archived)
solo-consultazione
Archived
2026-11-03T04:12:26.385Z
SHA-256 of the archived text
7cad9d711f805130f5dac0258f3c31bd070775ab54e1500e37b863da5c9ebf7b
Stable URL of this page
https://metraipolis.com/documento/dc_f3cc69218f55

How to cite

PD-L1-armored CD19/CD22 dual-targeted CAR-T cell co-infusion bridging to allogeneic hematopoietic stem cell transplantation achieves 7-year sustained… — Europe PMC PMID:42125659 — Europe PMC (en), https://europepmc.org/article/MED/42125659 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f3cc69218f55 (Metraipolis archive dc_f3cc69218f55, sha256 7cad9d711f805130f5dac0258f3c31bd070775ab54e1500e37b863da5c9ebf7b)
BibTeX
@misc{dcf3cc69218f55,
  title = {PD-L1-armored CD19/CD22 dual-targeted CAR-T cell co-infusion bridging to allogeneic hematopoietic stem cell transplantation achieves 7-year sustained… — Europe PMC PMID:42125659},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42125659},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f3cc69218f55; sha256 7cad9d711f805130f5dac0258f3c31bd070775ab54e1500e37b863da5c9ebf7b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42125659. Agents can read the archived copy with the MCP tool read_document.